Loading company…
Riskpilot
← Back to search
Sign in
Get full access
IgY Lab Systems AB
AB
Active
Org 5592381080
Boksta 505
Research and experimental development on natural sciences and engineering · NACE 7210
Est. 2020
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
SEK 91K
-5% vs 2023
EBITDA margin
23.8%
-23% vs 2023
Equity ratio
60.7%
Financial strength
Net profit 2024
SEK 47K
+24% vs 2023
EBITDA — year on year
SEK millions
1M
1M
1M
0M
0M
1M
2020
0M
-100%
2021
1M
+100%
2022
0M
-100%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
SEK 91K
-5%
EBITDA
SEK 22K
-23%
Net profit
SEK 47K
+24%
Total assets
SEK 1,5M
+4%
Equity
SEK 935K
-37%
Employees
0
—
Company information
Legal name
IgY Lab Systems AB
Org number
5592381080
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
23 januari 2020
Share capital
SEK 60 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget ska bedriva forskning och utveckling av antikroppar samt försäljning därav, ävensom idka annan därmed förenlig verksamhet.
Contact
Address
Boksta 505
Email
kajsa@ovaprod.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Research and experimental development on natural sciences and engineering
Companies in Heby
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
1M
2020
1M
2021
1M
2022
0M
2023
0M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
1M
2020
0M
2021
1M
2022
0M
2023
0M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
952
650
747
96
91
Staff expenses
—
—
—
—
—
EBITDA
899
289
575
28
22
Depreciation & amort.
−0
−0
—
—
—
EBIT
899
289
575
28
22
Net financials
—
—
−2
21
38
Profit before tax
899
289
573
49
59
Tax
−192
−60
−119
−11
−12
Net profit
707
229
454
38
47
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
961
1 245
1 571
1 476
1 542
Equity
767
995
1 450
1 488
935
Long-term debt
0
0
—
—
—
Short-term debt
194
250
121
−12
607
Total debt
194
250
121
−12
607
Financial ratios
5-year trend
EBITDA margin
23.8%
This company
15.8%
Market median
+51% vs market
2020
2024
Equity ratio
60.7%
This company
38.2%
Market median
+59% vs market
2020
2024
Return on equity
5.1%
This company
18.4%
Market median
-72% vs market
2020
2024
Net profit margin
52.0%
This company
8.1%
Market median
+542% vs market
2020
2024
Asset turnover
0.06×
This company
1.12×
Market median
-95% vs market
2020
2024
Debt / equity
0.65×
This company
0.62×
Market median
+5% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
AO
Anders Olof Larsson
Board of Directors
2022
JH
Johan Harald Stålberg
Chairman
2022
KA
Kajsa Anna Therese Wejåker
Board of Directors
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of IgY Lab Systems AB also hold positions in
0
other companies.
Person
Role here
Other companies
Anders Olof Larsson
Board of Directors
0 companies
Johan Harald Stålberg
Chairman
0 companies
Kajsa Anna Therese Wejåker
Board of Directors
0 companies